Pacer Advisors Portfolio holdings
AUM
$39.6B
1-Year Return
5.04%
This Quarter Return
+10.34%
1 Year Return
+5.04%
3 Year Return
+42.86%
5 Year Return
+91.64%
10 Year Return
+332.32%
AUM
$5.32B
AUM Growth
+$623M
(+13%)
Cap. Flow
+$354M
Cap. Flow
% of AUM
6.65%
Top 10 Holdings %
Top 10 Hldgs %
31.02%
Holding
1,573
New
308
Increased
332
Reduced
859
Closed
60
Top Buys
| 1 |
Equinix
EQIX
|
+$41.9M |
| 2 |
American Tower
AMT
|
+$33.5M |
| 3 |
CD
Chindata Group Holdings Limited American Depositary Shares
CD
|
+$28M |
| 4 |
Crown Castle
CCI
|
+$20.9M |
| 5 |
CONE
CyrusOne Inc Common Stock
CONE
|
+$13.7M |
Top Sells
| 1 |
Apple
AAPL
|
+$89.3M |
| 2 |
Microsoft
MSFT
|
+$66.1M |
| 3 |
Amazon
AMZN
|
+$63.1M |
| 4 |
Meta Platforms (Facebook)
META
|
+$26.3M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$25.2M |
Sector Composition
| 1 | Real Estate | 18.33% |
| 2 | Technology | 16.47% |
| 3 | Consumer Discretionary | 8.8% |
| 4 | Healthcare | 7.69% |
| 5 | Communication Services | 7.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1201
BioCryst Pharmaceuticals
BCRX
$1.72B
| $119K | ﹤0.01% |
15,945
-8,558
| -35% | -$63.9K |
|
1202
Olympic Steel
ZEUS
$373M
| $119K | ﹤0.01% |
8,934
-2,275
| -20% | -$30.3K |
|
1203
Akebia Therapeutics
AKBA
$830M
| $117K | ﹤0.01% |
41,750
+37,032
| +785% | +$104K |
|
1204
Cytokinetics
CYTK
$6.23B
| $117K | ﹤0.01% |
5,631
+3,234
| +135% | +$67.2K |
|
1205
Novavax
NVAX
$1.26B
| $117K | ﹤0.01% |
1,046
-1,260
| -55% | -$141K |
|
1206
Opko Health
OPK
$1.13B
| $117K | ﹤0.01% |
29,738
-12,650
| -30% | -$49.8K |
|
1207
Vir Biotechnology
VIR
$721M
| $117K | ﹤0.01% |
4,378
+4,206
| +2,445% | +$112K |
|
|
SRNE
1208
DELISTED
Sorrento Therapeutics, Inc.
SRNE
| $117K | ﹤0.01% |
17,210
+3,904
| +29% | +$26.5K |
|
1209
Thomson Reuters
TRI
$78.2B
| $115K | ﹤0.01% |
+1,351
| New | +$115K |
|
1210
American Public Education
APEI
$583M
| $115K | ﹤0.01% |
3,779
+1,103
| +41% | +$33.6K |
|
1211
Pilgrim's Pride
PPC
$10.6B
| $114K | ﹤0.01% |
5,808
-6,748
| -54% | -$132K |
|
1212
Western Midstream Partners
WES
$14.5B
| $114K | ﹤0.01% |
8,253
-1,819
| -18% | -$25.1K |
|
1213
Mersana Therapeutics
MRSN
$35.1M
| $113K | ﹤0.01% |
170
+118
| +227% | +$78.4K |
|
1214
Fastly
FSLY
$1.11B
| $112K | ﹤0.01% |
+1,277
| New | +$112K |
|
1215
Immunovant
IMVT
$2.85B
| $111K | ﹤0.01% |
+2,410
| New | +$111K |
|
|
VBIV
1216
DELISTED
VBI Vaccines, Inc. New Common Stock (Canada)
VBIV
| $111K | ﹤0.01% |
+1,342
| New | +$111K |
|
1217
Esperion Therapeutics
ESPR
$506M
| $110K | ﹤0.01% |
4,236
+1,820
| +75% | +$47.3K |
|
1218
Insmed
INSM
$31B
| $110K | ﹤0.01% |
3,318
-548
| -14% | -$18.2K |
|
1219
Madrigal Pharmaceuticals
MDGL
$10.1B
| $110K | ﹤0.01% |
986
+150
| +18% | +$16.7K |
|
|
CLDR
1220
DELISTED
Cloudera, Inc.
CLDR
| $110K | ﹤0.01% |
7,900
-1,094
| -12% | -$15.2K |
|
|
TWOU
1221
DELISTED
2U, Inc.
TWOU
| $109K | ﹤0.01% |
91
+3
| +3% | +$3.59K |
|
1222
Veracyte
VCYT
$2.55B
| $108K | ﹤0.01% |
2,208
-172
| -7% | -$8.41K |
|
1223
Ironwood Pharmaceuticals
IRWD
$184M
| $107K | ﹤0.01% |
9,395
-332
| -3% | -$3.78K |
|
1224
Inovio Pharmaceuticals
INO
$153M
| $106K | ﹤0.01% |
997
+324
| +48% | +$34.4K |
|
|
CNH
1225
CNH Industrial
CNH
$14.4B
| $106K | ﹤0.01% |
+9,462
| New | +$106K |
|